Current approaches in dendritic cell generation and future implications for cancer immunotherapy (Q36822028)

16 August 2017

1 reference

title

Current approaches in dendritic cell generation and future implications for cancer immunotherapy (English)

1 reference

16 August 2017

1 reference

1 reference

Sandra Tuyaerts

1 reference

16 August 2017

Joeri L Aerts

1 reference

16 August 2017

Jurgen Corthals

1 reference

16 August 2017

Bart Neyns

1 reference

16 August 2017

Carlo Heirman

1 reference

16 August 2017

Karine Breckpot

1 reference

16 August 2017

Kris Thielemans

1 reference

16 August 2017

Aude Bonehill

1 reference

16 August 2017

publication date

15 May 2007

1 reference

Cancer Immunology, Immunotherapy

16 August 2017

published in

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

1513-1537

1 reference

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

IFN-α Skews Monocyte Differentiation into Toll-Like Receptor 7-Expressing Dendritic Cells with Potent Functional Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0334-Z

10.1007/S00262-007-0334-Z

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference